Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial origin

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 10, 2008, Pages 1639-1644

  Pruissen, D M O ^a   Rosendaal, F R ^b   Frijns, C J M ^a   Kappelle, L J ^a   Vos, H L ^b   Algra, Ale ^a,b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Cerebral ischemia; Gene variation; Genetics; Ischemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIPYRIDAMOLE;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY HOSPITAL; VASCULAR DISEASE;

ARTERIES; BRAIN ISCHEMIA; CAUSE OF DEATH; COHORT STUDIES; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC VARIATION; HUMANS; NETHERLANDS; RECURRENCE; RISK; THROMBOSIS; VASCULAR DISEASES;

EID: 52449120389     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03097.x     Document Type: Article

References (22)

1. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35: 212-27.
2. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: A family history study. Stroke 2003; 34: 1364-9.
3. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004; 61: 1652-61.
4. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651-8.
5. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 2005; 36: 2027-31.
6. Pruissen DM, Kappelle LJ, Algra A. Polymorphisms and Risk of Ischemic Stroke (POLARIS) study: Rationale and design. Eur Neurol 2004; 51: 30-4.
7. Simons PC, Algra A, van deLaak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: Rationale and design. Eur J Epidemiol 1999; 15: 773-81.
8. ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet 2006; 367: 1665-73.
9. ESPRIT Study Group. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): A randomised controlled trial. Lancet Neurol 2007; 6: 115-24.
10. De Schryver EL, Algra A, Donders RC, van Gijn J, Kappelle LJ. Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin. J Neurol Neurosurg Psychiatry 2006; 77: 734-8.
11. Pruissen DM, Gerritsen SA, Prinsen TJ, Dijk JM, Kappelle LJ, Algra A. Carotid intima-media thickness is different in large- and small-vessel ischemic stroke: The SMART study. Stroke 2007; 38: 1371-3.
12. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
13. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Classification of cause of death after stroke in clinical research. Stroke 2006; 37: 1521-4.
14. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet 2002; 359: 1309-10.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289-300.
16. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, Lumley T, Bis JC, Wiggins KL, Rosendaal FR, Psaty BM. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007; 297: 489-98.
17. Dupuis J, O'Donnell CJ. Interpreting results of large-scale genetic association studies: Separating gold from fool's gold. JAMA 2007; 297: 529-31.
18. Flossmann E, Rothwell PM. Family history of stroke does not predict risk of stroke after transient ischemic attack. Stroke 2006; 37: 544-6.
19. Dippel DW, Koudstaal PJ. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group. Stroke 1997; 28: 774-6.
20. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-72.
21. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P. Genetics of ischaemic stroke among persons of non-European descent: A meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 2007; 4: E131.
22. Reitsma PH. No praise for folly: Genomics will never be useful in arterial thrombosis. J Thromb Haemost 2007; 5: 454-7.